首页> 美国卫生研究院文献>Nucleic Acids Research >Molecular basis of titin exon exclusion by RBM20 and the novel titin splice regulator PTB4
【2h】

Molecular basis of titin exon exclusion by RBM20 and the novel titin splice regulator PTB4

机译:RBM20和新型钛蛋白剪接调节剂PTB4排除钛蛋白外显子的分子基础

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

RNA-binding motif protein 20 (RBM20) is a cardiac splice regulator that adapts cardiac filling via its diverse substrates—including the sarcomeric protein titin. The molecular basis and regulation of RBM20-dependent exon exclusion are largely unknown. In tissue culture experiments, we show that the combination of RNA recognition motif (RRM) and C-terminus is necessary and sufficient for RBM20 activity, indicating an important function of the ZnF2 domain in splicing repression. Using splice reporter and in vitro binding assays targeting titin exons 241–243, we identified a minimal genomic segment that is necessary for RBM20-mediated splicing repression of the alternative exon. Here, RBM20 binds the cluster containing most RBM20 binding motifs through its RRM domain and represses the upstream and downstream introns. For subsequent exon exclusion, specific regions upstream, downstream and within the alternative exon 242 are required. Regulation of exon exclusion involves PTB4 as a novel titin splice regulator, which counteracts RBM20 repressor activity in HEK293 cells. Together, these mechanistic insights into the regulation and action of RBM20 and PTB4 provide a basis for the future development of RBM20 modulators that adapt titin elasticity in cardiac disease.
机译:RNA结合基序蛋白20(RBM20)是一种心脏剪接调节剂,可通过其多种底物(包括肌节蛋白titin)适应心脏充盈。 RBM20依赖的外显子排斥的分子基础和调节是很大程度上未知。在组织培养实验中,我们显示RNA识别基序(RRM)和C端的组合对于RBM20活性是必要且充分的,表明ZnF2域在剪接抑制中具有重要作用。使用针对纤连蛋白外显子241-243的剪接报告基因和体外结合测定,我们确定了RBM20介导的替代性外显子抑制所必需的最小基因组片段。在这里,RBM20通过其RRM结构域结合包含大多数RBM20结合基序的簇,并抑制上游和下游内含子。对于随后的外显子排除,需要替代外显子242上游,下游和内部的特定区域。外显子排除的调控涉及PTB4作为新型的纤体剪接调节剂,它可抵消HEK293细胞中RBM20阻遏物的活性。综上所述,这些对RBM20和PTB4调控和作用的机械性见解为适应心脏疾病中钛蛋白弹性的RBM20调节剂的未来发展提供了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号